Samrat Pharmachem Ltd
BSE:530125

Watchlist Manager
Samrat Pharmachem Ltd Logo
Samrat Pharmachem Ltd
BSE:530125
Watchlist
Price: 215 INR -2.89% Market Closed
Market Cap: 664.4m INR

Operating Margin

1.2%
Current
Declining
by 2%
vs 3-y average of 3.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.2%
=
Operating Income
₹33.8m
/
Revenue
₹2.9B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
1.2%
=
Operating Income
₹33.8m
/
Revenue
₹2.9B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Samrat Pharmachem Ltd
BSE:530125
668.9m INR
Loading...
US
Sherwin-Williams Co
NYSE:SHW
88.7B USD
Loading...
US
Ecolab Inc
NYSE:ECL
78.5B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.7T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
258B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
28.9B CHF
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.6T INR
Loading...
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
US
PPG Industries Inc
NYSE:PPG
24.7B USD
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
CH
DSM-Firmenich AG
AEX:DSFIR
17.2B EUR
Loading...
No Stocks Found

Market Distribution

Lower than 75% of companies in India
Percentile
25th
Based on 5 437 companies
25th percentile
1.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Samrat Pharmachem Ltd
Glance View

Market Cap
664.4m INR
Industry
Chemicals

Samrat Pharmachem Ltd. engages in the manufacturing manufacturing and selling chemicals. The company is headquartered in Mumbai, Maharashtra. The firm is a supplier of iodine derivatives to the Indian and foreign market. The Company’s products include 3-5-Di Iodosalicylic Acid, Ammonium Iodide, Calcium Iodide, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodic Acid, Iodine, Iodine Monochloride, Iodoquinol, Lithium Iodide, Methyl Iodide, N-Iodo Succcinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate, Sodium Selenite, Tetra Butyl Ammonium Iodide, and Tri Methyl Sulphoxonium Iodide. The company serves various industries, such as agrochemical, animal feed, chemicals, food, pharmaceutical, printing, and textile. The firm exports its products to various countries, including United States, Europe, Africa, Asia, and Middle East.

SAMRATPH Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
1.2%
=
Operating Income
₹33.8m
/
Revenue
₹2.9B
What is Samrat Pharmachem Ltd's current Operating Margin?

The current Operating Margin for Samrat Pharmachem Ltd is 1.2%, which is below its 3-year median of 3.2%.

How has Operating Margin changed over time?

Over the last 3 years, Samrat Pharmachem Ltd’s Operating Margin has decreased from 14.4% to 1.2%. During this period, it reached a low of -0.1% on Dec 31, 2023 and a high of 14.4% on Aug 30, 2022.

Back to Top